ArticleFrontiers in oncology2022

CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review.

Mingyu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.